Advertisers may indicate that prescribers can write “no sub” on a prescription in promotional material. However, such presentations should not suggest that writing “no sub” on a prescription can ensure that patients will receive the prescribed brand name product. There are various reasons for why a patient may not receive the prescribed brand name product, including the patient opting for a generic product and conditions for reimbursement.
Following a formal healthcare professional complaint, statements similar to “Help make sure that your patients receives Brand X by writing “no sub” on their prescriptions” will not be accepted. “Make sure” suggests a guarantee and has absolute implications, the addition of “help” notwithstanding. An acceptable alternative is “Help your patients receive Brand X by writing “no sub” on their prescriptions”. A disclaimer indicating limitations and conditions should be included as copy-specific fair balance. An example of such a disclaimer is “Some insurers limit full-cost coverage for higher-cost interchangeable drugs to patients who meet certain criteria and that, in some instances, documentation from the prescriber is required. There is a possibility that the patient may need to contribute out-of-pocket where those conditions are not met”.
Never miss an update. Get the latest PAAB info delivered right to your email address.
In an effort to constantly serve our clients better, PAAB has unveiled a new electronic submission process(eFiles). Effective January 2, 2008 all submissions will have to be submitted via the eFiles system. Please have a Senior Official (Director level) send an email to the administration team at review@paab.ca with the contact information of the person(s) who will be designated as administrator(s) for your company. Click on eFiles, on the menu, then eFiles Tutorial for a tutorial on how eFiles works.
Please contact the admin team at PAAB if you need assistance with eFiles
The Accelerated Preclearance Pathway
Learn more and share your feedback by April 14
Click here to provide feedback